Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Second or Third Additional Chemotherapy Drug for Non-small Cell Lung Cancer in Patients With Advanced Disease: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/. Accessed 15 May 2024.
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/. Accessed May 15, 2024.
Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/
Second or Third Additional Chemotherapy Drug for Non-small Cell Lung Cancer in Patients With Advanced Disease: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 May 15]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Second or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced disease: Cochrane systematic review
ID - 434883
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/434883/all/
DB - Evidence Central
DP - Unbound Medicine
ER -